10th Annual HealthTech Investment Forum

FOCUSING ON DIGITAL HEALTH, MEDTECH & DEVICES

19th of September 2023|MÖVENPICK HOTEL | BASEL | SWITZERLAND

SILVER SPONSOR:

Basel+ Logo

Basel+

The Canton of Basel-Stadt contributes to the further development of convention-related tourism. Conventions are specifically acquired, developed and held, thus accessing a potential not yet exploited with benefits beyond tourism. The objective of convention promotion is to increase the direct and indirect added value generated by conventions. Additionally, a further strengthening of Basel as the most innovative economic location and center of knowledge in Switzerland is targeted. By promoting conventions, we want to contribute to Basel remaining one of the most important trade fair and convention cities in Europe.

CONTRIBUTING SPONSORS:

Canton of Basel-Stadt Logo

Canton of Basel-Stadt

An economic powerhouse situated on the border of three countries, Basel-Stadt offers a very dynamic business environment. A healthy ecosystem thrives on its diversity to enrich and pollinate each other. Existing blue-chip companies, international companies that settle here, leading research institutes and SME’s rub shoulders with vibrant startups, prolific incubators and multinationals which thrive in the area. Born in the nucleus of life sciences innovation, Basel-Stadt flourishes as an international hub of innovation, culture and business acumen.
 
Switzerland is considered the most innovative country in the world, according to a number of studies. Access to knowledge, highly qualified and international talent and a supportive government have turned Basel into the leading innovation hub of Switzerland. A future-oriented outlook with continuous innovation marks Basel as an international leader in life sciences, healthcare, ICT technology and circular economy.

With a population of 200,000, Basel may seem to be a small city, but its rich economic and cultural offerings put it firmly in the big league. Many international companies and well-known brands such as Novartis, Roche, Lonza, Moderna, BeiGgene, Bayer and Syngenta have their headquarters here, and the city has a thriving, multi-cultural, well-educated expat community coming from more than 160 different countries.

PharmaVentures Ltd. Logo

PharmaVentures Ltd.

PharmaVentures is a premier transaction advisory firm and a leading international company in partnering, M&A deals and strategic alliances. For over 30 years, PharmaVentures has acted as advisor on over 1000 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide. PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest. PharmaVentures’ services include: · M&A (divestments, mergers, acquisitions, and strategic transactions) · Licensing (in and out licensing) · Fundraising Support · Strategy (commercialisation, deal strategy, due diligence, market entry) · Valuations (licensing, M&A and fundraising) · Pricing and Market Access PharmaVentures is based in London, UK, and employs over 30 professionals and has associates in Asia-Pacific. PharmaVentures Capital Ltd is a wholly owned subsidiary of PharmaVentures Ltd. All regulated activities are delivered through PharmaVentures Capital Ltd, which is authorised and regulated by the Financial Conduct Authority (741356).